Found: 5
Select item for more details and to access through your institution.
CA-CAS-01-A: A Permissive Cell Line for Isolation and Live Attenuated Vaccine Development Against African Swine Fever Virus.
- Published in:
- Journal of Microbiology, 2024, v. 62, n. 2, p. 125, doi. 10.1007/s12275-024-00116-1
- By:
- Publication type:
- Article
High-Level Expression of Recombinant VHSV Glycoprotein Using Transformed C. vulgaris and Verification of Vaccine Efficacy.
- Published in:
- Vaccines, 2023, v. 11, n. 7, p. 1205, doi. 10.3390/vaccines11071205
- By:
- Publication type:
- Article
Efficacy of a Novel Multiepitope Vaccine Candidate against Foot-and-Mouth Disease Virus Serotype O and A.
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 2181, doi. 10.3390/vaccines10122181
- By:
- Publication type:
- Article
The Potential Adjuvanticity of CAvant ® SOE for Foot-and-Mouth Disease Vaccine.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1091, doi. 10.3390/vaccines9101091
- By:
- Publication type:
- Article
Hyper-Enhanced Production of Foreign Recombinant Protein by Fusion with the Partial Polyhedrin of Nucleopolyhedrovirus.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0060835
- By:
- Publication type:
- Article